首页 > 最新文献

Cellular and Molecular Gastroenterology and Hepatology最新文献

英文 中文
The Evolution of CMGH as The Basic Research Journal in Gastroenterology and Hepatology: "H" is for "Home".
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-22 DOI: 10.1016/j.jcmgh.2024.101450
Jonathan P Katz, Michele A Battle, Alexander M Vaeth
{"title":"The Evolution of CMGH as The Basic Research Journal in Gastroenterology and Hepatology: \"H\" is for \"Home\".","authors":"Jonathan P Katz, Michele A Battle, Alexander M Vaeth","doi":"10.1016/j.jcmgh.2024.101450","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2024.101450","url":null,"abstract":"","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101450"},"PeriodicalIF":7.1,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vivo CRISPR Activation Screening, a Powerful Tool to Discover Oncogenic Driver Genes in Hepatocellular Carcinoma.
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-21 DOI: 10.1016/j.jcmgh.2024.101459
Shaimaa Gad, Ruisong Ye, Wei Qiu
{"title":"In vivo CRISPR Activation Screening, a Powerful Tool to Discover Oncogenic Driver Genes in Hepatocellular Carcinoma.","authors":"Shaimaa Gad, Ruisong Ye, Wei Qiu","doi":"10.1016/j.jcmgh.2024.101459","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2024.101459","url":null,"abstract":"","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101459"},"PeriodicalIF":7.1,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143043224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dysregulated Proteostasis-induced Ferroptosis in Gastroesophageal Reflux Disease: Hero or Villain? 胃食管反流病中蛋白稳态失调诱导的铁蛋白沉积:英雄还是恶棍?
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-17 DOI: 10.1016/j.jcmgh.2024.101445
David H Wang
{"title":"Dysregulated Proteostasis-induced Ferroptosis in Gastroesophageal Reflux Disease: Hero or Villain?","authors":"David H Wang","doi":"10.1016/j.jcmgh.2024.101445","DOIUrl":"10.1016/j.jcmgh.2024.101445","url":null,"abstract":"","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101445"},"PeriodicalIF":7.1,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142907896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nothing but NET: A Novel Model of Alcohol Induced Acute-on-Chronic Liver Failure Demonstrates Both Enhanced Mechanistic Insight and a Possible Therapeutic Pathway. NET:一种酒精诱导的急性慢性肝衰竭的新模型显示了增强的机制洞察和可能的治疗途径。
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-17 DOI: 10.1016/j.jcmgh.2024.101455
Shagun Sharma, Thomas Wallach
{"title":"Nothing but NET: A Novel Model of Alcohol Induced Acute-on-Chronic Liver Failure Demonstrates Both Enhanced Mechanistic Insight and a Possible Therapeutic Pathway.","authors":"Shagun Sharma, Thomas Wallach","doi":"10.1016/j.jcmgh.2024.101455","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2024.101455","url":null,"abstract":"","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101455"},"PeriodicalIF":7.1,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Molecular Player In Colitis and Colitis-Associated Cancer. 结肠炎和结肠炎相关癌症的新分子参与者。
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-15 DOI: 10.1016/j.jcmgh.2024.101441
Kim E Barrett
{"title":"New Molecular Player In Colitis and Colitis-Associated Cancer.","authors":"Kim E Barrett","doi":"10.1016/j.jcmgh.2024.101441","DOIUrl":"10.1016/j.jcmgh.2024.101441","url":null,"abstract":"","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101441"},"PeriodicalIF":7.1,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142886517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PKMζ: A Brain Kinase Driving Metabolic Reprogramming and Myofibroblastic Differentiation. PKMζ:驱动代谢重编程和肌成纤维细胞分化的脑激酶。
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-15 DOI: 10.1016/j.jcmgh.2024.101437
Aveline Filliol
{"title":"PKMζ: A Brain Kinase Driving Metabolic Reprogramming and Myofibroblastic Differentiation.","authors":"Aveline Filliol","doi":"10.1016/j.jcmgh.2024.101437","DOIUrl":"10.1016/j.jcmgh.2024.101437","url":null,"abstract":"","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101437"},"PeriodicalIF":7.1,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142886518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The histamine pathway is a target to treat hepatic experimental erythropoietic protoporphyria. 组胺途径是治疗肝实验性红细胞原卟啉症的靶点。
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-15 DOI: 10.1016/j.jcmgh.2025.101463
Ning Kuo, Pei Li, Juliana Bragazzi Cunha, Lu Chen, Jordan A Shavit, M Bishr Omary

Background & aims: Erythropoietic protoporphyria (EPP) is caused by mutations in ferrochelatase which inserts iron into protoporphyrin-IX (PP-IX) to generate heme. EPP is characterized by PP-IX accumulation, skin photosensitivity, cholestasis, and end-stage liver disease. Despite available drugs that address photosensitivity, treatment of EPP-related liver disease remains an unmet need.

Methods: We administered delta-aminolaevulinic acid (ALA) and deferoxamine (DFO), which results in PP-IX overproduction and accumulation. High-throughput compound screening of ALA+DFO-treated zebrafish identified chlorcyclizine (first generation H1-antihistamine receptor blocker), as a drug that reduces zebrafish liver PP-IX levels. The effect of chlorcyclizine was validated in porphyrin-loaded primary mouse hepatocytes (PMH), transgenic Fechm1Pas EPP mice, and mice fed the porphyrinogenic compound 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). Plasma and tissue PP-IX were measured by fluorescence; livers were analyzed by histology, immunoblotting, and qPCR.

Results: Chlorcyclizine-treated zebrafish larvae, DDC-fed and transgenic EPP mice manifested reduced hepatic PP-IX levels compared to controls. Histamine increased PP-IX accumulation in porphyrin-stressed hepatocytes, while H1/H2-receptor blockade decreased PP-IX levels. In both mouse models, chlorcyclizine lowered PP-IX level in female but not male mice in liver, erythrocytes, and bone marrow; improved liver injury; decreased porphyrin-triggered protein aggregation and oxidation; and increased clearance of stool PP-IX. In PMH, chlorcyclizine induced nuclear translocation of constitutive androstane and farnesoid X receptors, and transactivated bile acid transporter expression. Knockdown of the transporters BSEP and MRP4 led to increased detection of sequestosome-1 (p62 protein) high-molecular-weight species. Chlorcyclizine also reduced hepatic mast cell number and histamine level in EPP mice.

Conclusions: Histamine plays an important role in PP-IX accumulation in zebrafish and two experimental EPP models. Chlorcyclizine and/or other antihistamines, provide a potential therapeutic strategy to treat EPP-associated liver disease via decreasing PP-IX accumulation.

背景与目的:红细胞生成性原卟啉症(EPP)是由铁螯合酶突变引起的,该酶将铁插入原卟啉- ix (PP-IX)中产生血红素。EPP的特征是PP-IX积聚、皮肤光敏、胆汁淤积和终末期肝病。尽管现有的药物可以解决光敏性问题,但epp相关肝病的治疗仍然是一个未满足的需求。方法:给药氨基乙酸(ALA)和去铁胺(DFO)导致PP-IX过量产生和积累。对ALA+ dfo处理的斑马鱼进行高通量化合物筛选,发现氯环嗪(第一代h1 -抗组胺受体阻滞剂)可降低斑马鱼肝脏PP-IX水平。在载卟啉原代小鼠肝细胞(PMH)、转基因Fechm1Pas EPP小鼠和饲喂卟啉源化合物3,5-二氧羰基-1,4-二氢碰撞碱(DDC)的小鼠中验证了氯环嗪的作用。荧光法测定血浆和组织中PP-IX;采用组织学、免疫印迹和qPCR对肝脏进行分析。结果:与对照组相比,氯环嘧啶处理的斑马鱼幼虫、ddc喂养的和转基因EPP小鼠的肝脏PP-IX水平降低。组胺增加了卟啉应激肝细胞中PP-IX的积累,而H1/ h2受体阻断降低了PP-IX的水平。在两种小鼠模型中,氯环利嗪均能降低雌性小鼠肝脏、红细胞和骨髓中的PP-IX水平,而雄性小鼠没有;改善肝损伤;卟啉引发的蛋白聚集和氧化减少;并增加粪便PP-IX的清除率。在PMH中,氯环嗪诱导构成雄甾烷和法内酯X受体的核易位,并激活胆汁酸转运体的表达。转运蛋白BSEP和MRP4的敲低导致高分子量物种sequestosome-1 (p62蛋白)的检测增加。氯环利嗪还能降低EPP小鼠肝肥大细胞数量和组胺水平。结论:组胺在斑马鱼和两种实验性EPP模型中PP-IX积累中起重要作用。氯环嗪和/或其他抗组胺药通过减少PP-IX的积累,为治疗epp相关的肝脏疾病提供了一种潜在的治疗策略。
{"title":"The histamine pathway is a target to treat hepatic experimental erythropoietic protoporphyria.","authors":"Ning Kuo, Pei Li, Juliana Bragazzi Cunha, Lu Chen, Jordan A Shavit, M Bishr Omary","doi":"10.1016/j.jcmgh.2025.101463","DOIUrl":"10.1016/j.jcmgh.2025.101463","url":null,"abstract":"<p><strong>Background & aims: </strong>Erythropoietic protoporphyria (EPP) is caused by mutations in ferrochelatase which inserts iron into protoporphyrin-IX (PP-IX) to generate heme. EPP is characterized by PP-IX accumulation, skin photosensitivity, cholestasis, and end-stage liver disease. Despite available drugs that address photosensitivity, treatment of EPP-related liver disease remains an unmet need.</p><p><strong>Methods: </strong>We administered delta-aminolaevulinic acid (ALA) and deferoxamine (DFO), which results in PP-IX overproduction and accumulation. High-throughput compound screening of ALA+DFO-treated zebrafish identified chlorcyclizine (first generation H1-antihistamine receptor blocker), as a drug that reduces zebrafish liver PP-IX levels. The effect of chlorcyclizine was validated in porphyrin-loaded primary mouse hepatocytes (PMH), transgenic Fech<sup>m1Pas</sup> EPP mice, and mice fed the porphyrinogenic compound 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). Plasma and tissue PP-IX were measured by fluorescence; livers were analyzed by histology, immunoblotting, and qPCR.</p><p><strong>Results: </strong>Chlorcyclizine-treated zebrafish larvae, DDC-fed and transgenic EPP mice manifested reduced hepatic PP-IX levels compared to controls. Histamine increased PP-IX accumulation in porphyrin-stressed hepatocytes, while H1/H2-receptor blockade decreased PP-IX levels. In both mouse models, chlorcyclizine lowered PP-IX level in female but not male mice in liver, erythrocytes, and bone marrow; improved liver injury; decreased porphyrin-triggered protein aggregation and oxidation; and increased clearance of stool PP-IX. In PMH, chlorcyclizine induced nuclear translocation of constitutive androstane and farnesoid X receptors, and transactivated bile acid transporter expression. Knockdown of the transporters BSEP and MRP4 led to increased detection of sequestosome-1 (p62 protein) high-molecular-weight species. Chlorcyclizine also reduced hepatic mast cell number and histamine level in EPP mice.</p><p><strong>Conclusions: </strong>Histamine plays an important role in PP-IX accumulation in zebrafish and two experimental EPP models. Chlorcyclizine and/or other antihistamines, provide a potential therapeutic strategy to treat EPP-associated liver disease via decreasing PP-IX accumulation.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101463"},"PeriodicalIF":7.1,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enteric neuronal substrates underlying spontaneous and evoked neurogenic contractions in mouse colon. 小鼠结肠自发性和诱发性神经源性收缩的肠神经元底物。
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-13 DOI: 10.1016/j.jcmgh.2025.101462
Sushmita Debnath, Dante J Heredia, Nicole M Procacci, Camila Fedi, Emer P Ni Bhraonain, Caroline A Cobine, Thomas W Gould

Background and aims: Gastrointestinal motility persists when peripheral cholinergic signaling is blocked genetically or pharmacologically, and a recent study suggests nitric oxide drives propagating neurogenic contractions.

Methods: To determine the neuronal substrates that underlie these contractions, we measured contractile-associated movements together with calcium responses of cholinergic or nitrergic myenteric neurons in un-paralyzed ex vivo preparations of whole mouse colon. We chose to look at these two subpopulations because they encompass nearly all myenteric neurons.

Results: Many but not all cholinergic neurons of the middle colon exhibited contractile-associated calcium responses with distinct features. By contrast, a large population of nitrergic neurons of the middle colon shut their activity off just before contraction onset, whereas another population of nitrergic neurons initiated a response just after contraction onset. When contractions were evoked by a variety of stimuli to the proximal and distal colon, the same neuronal subtypes exhibited the same activity patterns during the contraction. However, stimulation of proximal colon produced a transient, stimulation-locked response before the ensuing contraction in a subpopulation of cholinergic neurons and in nearly all nitrergic neurons, suggesting that distinct neuronal activity patterns underlie specific stimuli. Finally, although blockade of nitric oxide failed to arrest the generation or propagation of neurogenic contractions, chemogenetic elimination of nitrergic activity impaired their propagation to middle and distal colon.

Conclusions: Genetic approaches were used to study the activity patterns of enteric neurons underlying spontaneous and evoked neurogenic contractions in un-paralyzed colon. These approaches can be combined with a variety of other approaches to identify the neuronal subtypes and subclasses that coordinate colonic motility.

背景和目的:当外周胆碱能信号被遗传或药理学阻断时,胃肠运动持续存在,最近的一项研究表明,一氧化氮驱动传播性神经源性收缩。方法:为了确定这些收缩背后的神经元基质,我们测量了未瘫痪小鼠全结肠离体制剂中胆碱能或氮能肌肠神经元的收缩相关运动和钙反应。我们选择研究这两个亚群是因为它们几乎包含了所有的肌肠神经元。结果:许多(但不是全部)中结肠胆碱能神经元表现出明显的收缩性钙反应。相比之下,中间结肠的大量氮能神经元在收缩开始前关闭了它们的活动,而另一群氮能神经元在收缩开始后才开始反应。当结肠近端和远端受到各种刺激而引起收缩时,相同的神经元亚型在收缩期间表现出相同的活动模式。然而,在胆碱能神经元亚群和几乎所有的氮能神经元中,对近端结肠的刺激在随后的收缩之前产生了短暂的、刺激锁定的反应,这表明不同的神经元活动模式是特定刺激的基础。最后,尽管一氧化氮的阻断不能阻止神经源性收缩的产生或传播,但化学成因消除氮活性会损害其向中结肠和远结肠的传播。结论:采用遗传学方法研究了未瘫痪结肠自发性和诱发性神经源性收缩的肠神经元活动模式。这些方法可以与各种其他方法相结合,以确定协调结肠运动的神经元亚型和亚类。
{"title":"Enteric neuronal substrates underlying spontaneous and evoked neurogenic contractions in mouse colon.","authors":"Sushmita Debnath, Dante J Heredia, Nicole M Procacci, Camila Fedi, Emer P Ni Bhraonain, Caroline A Cobine, Thomas W Gould","doi":"10.1016/j.jcmgh.2025.101462","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2025.101462","url":null,"abstract":"<p><strong>Background and aims: </strong>Gastrointestinal motility persists when peripheral cholinergic signaling is blocked genetically or pharmacologically, and a recent study suggests nitric oxide drives propagating neurogenic contractions.</p><p><strong>Methods: </strong>To determine the neuronal substrates that underlie these contractions, we measured contractile-associated movements together with calcium responses of cholinergic or nitrergic myenteric neurons in un-paralyzed ex vivo preparations of whole mouse colon. We chose to look at these two subpopulations because they encompass nearly all myenteric neurons.</p><p><strong>Results: </strong>Many but not all cholinergic neurons of the middle colon exhibited contractile-associated calcium responses with distinct features. By contrast, a large population of nitrergic neurons of the middle colon shut their activity off just before contraction onset, whereas another population of nitrergic neurons initiated a response just after contraction onset. When contractions were evoked by a variety of stimuli to the proximal and distal colon, the same neuronal subtypes exhibited the same activity patterns during the contraction. However, stimulation of proximal colon produced a transient, stimulation-locked response before the ensuing contraction in a subpopulation of cholinergic neurons and in nearly all nitrergic neurons, suggesting that distinct neuronal activity patterns underlie specific stimuli. Finally, although blockade of nitric oxide failed to arrest the generation or propagation of neurogenic contractions, chemogenetic elimination of nitrergic activity impaired their propagation to middle and distal colon.</p><p><strong>Conclusions: </strong>Genetic approaches were used to study the activity patterns of enteric neurons underlying spontaneous and evoked neurogenic contractions in un-paralyzed colon. These approaches can be combined with a variety of other approaches to identify the neuronal subtypes and subclasses that coordinate colonic motility.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101462"},"PeriodicalIF":7.1,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myosin light chain 9 mediates graft fibrosis after pediatric liver transplantation through TLR4/MYD88/NF-κB signaling. 肌球蛋白轻链9通过TLR4/MYD88/NF-κB信号介导小儿肝移植后移植物纤维化。
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-06 DOI: 10.1016/j.jcmgh.2024.101453
Zhixin Zhang, Chong Dong, Shengqiao Zhao, Zhuyuan Si, Weiping Zheng, Kai Wang, Chao Sun, Zhuolun Song, Wei Gao

Background & aims: The incidence of graft fibrosis is elevated following pediatric liver transplantation (pLT) and is influenced by cold ischemic time (CIT). Myosin light chain 9 (MYL9), a member of the myosin family, could act on hepatic stellate cells (HSCs) and induce a transition to active phase. We hypothesized that cold ischemic injury could stimulate MYL9 expression and lead to graft fibrosis.

Methods: We tested the hypothesis by analyzing multi-omics data from human protocol liver biopsy samples 2 years after liver transplant, performing rat LT with different CIT and conducting in vitro studies in HSC cell lines with MYL9 knockdown and overexpression.

Results: Clinically, CIT is an independent risk factor for graft fibrosis after pLT. Omics analysis identified MYL9 as a prominent contributor in graft fibrosis. MYL9 is strongly correlated with liver fibrosis grade, and the progression of fibrosis. The study of rat LT model demonstrated MYL9 expression increases with the prolongation of CIT and its role is specific to transplant setting. Mechanistically, in vitro experiments with HSCs exposed to hypoxia/reoxygenation revealed a substantial decrease in HSCs activation following MYL9 knockdown. Conversely, overexpression of the MYL9 significantly enhanced the activation of HSCs. Subsequent transcriptome sequencing of HSCs with MYL9 knockdown unveiled that MYL9 primarily functions through the TLR4/MYD88/NF-κB signaling pathway. Liver graft fibrosis was ameliorated when TLR4 signaling was inhibited in rats.

Conclusions: Our findings demonstrates the prolonged CIT upregulates the expression of MYL9 in liver graft after LT. MYL9 activates HSCs and promotes fibrosis through a TLR4/MYD88/NF-κB signaling dependent manner.

背景与目的:儿童肝移植(pLT)术后移植物纤维化发生率升高,并受冷缺血时间(CIT)的影响。Myosin轻链9 (MYL9)是Myosin家族的一员,可作用于肝星状细胞(hsc)并诱导其向活化期过渡。我们假设冷缺血损伤可刺激MYL9表达并导致移植物纤维化。方法:我们通过分析肝移植后2年人类方案肝活检样本的多组学数据,进行不同CIT的大鼠肝移植,并在MYL9敲低和过表达的HSC细胞系中进行体外研究,来验证这一假设。结果:临床上,CIT是pLT术后移植物纤维化的独立危险因素。组学分析发现MYL9在移植物纤维化中起着重要作用。MYL9与肝纤维化等级和纤维化进展密切相关。大鼠LT模型研究表明,MYL9的表达随着CIT的延长而增加,其作用是移植环境特有的。机制上,造血干细胞暴露于缺氧/再氧化的体外实验显示,MYL9敲除后造血干细胞的活化显著降低。相反,MYL9的过表达显著增强了hsc的活化。随后对MYL9敲低的hsc进行转录组测序,发现MYL9主要通过TLR4/MYD88/NF-κB信号通路发挥作用。抑制TLR4信号可改善大鼠移植肝纤维化。结论:我们的研究结果表明,延长CIT可上调肝移植后MYL9的表达,MYL9通过TLR4/MYD88/NF-κB信号依赖性激活hsc,促进肝纤维化。
{"title":"Myosin light chain 9 mediates graft fibrosis after pediatric liver transplantation through TLR4/MYD88/NF-κB signaling.","authors":"Zhixin Zhang, Chong Dong, Shengqiao Zhao, Zhuyuan Si, Weiping Zheng, Kai Wang, Chao Sun, Zhuolun Song, Wei Gao","doi":"10.1016/j.jcmgh.2024.101453","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2024.101453","url":null,"abstract":"<p><strong>Background & aims: </strong>The incidence of graft fibrosis is elevated following pediatric liver transplantation (pLT) and is influenced by cold ischemic time (CIT). Myosin light chain 9 (MYL9), a member of the myosin family, could act on hepatic stellate cells (HSCs) and induce a transition to active phase. We hypothesized that cold ischemic injury could stimulate MYL9 expression and lead to graft fibrosis.</p><p><strong>Methods: </strong>We tested the hypothesis by analyzing multi-omics data from human protocol liver biopsy samples 2 years after liver transplant, performing rat LT with different CIT and conducting in vitro studies in HSC cell lines with MYL9 knockdown and overexpression.</p><p><strong>Results: </strong>Clinically, CIT is an independent risk factor for graft fibrosis after pLT. Omics analysis identified MYL9 as a prominent contributor in graft fibrosis. MYL9 is strongly correlated with liver fibrosis grade, and the progression of fibrosis. The study of rat LT model demonstrated MYL9 expression increases with the prolongation of CIT and its role is specific to transplant setting. Mechanistically, in vitro experiments with HSCs exposed to hypoxia/reoxygenation revealed a substantial decrease in HSCs activation following MYL9 knockdown. Conversely, overexpression of the MYL9 significantly enhanced the activation of HSCs. Subsequent transcriptome sequencing of HSCs with MYL9 knockdown unveiled that MYL9 primarily functions through the TLR4/MYD88/NF-κB signaling pathway. Liver graft fibrosis was ameliorated when TLR4 signaling was inhibited in rats.</p><p><strong>Conclusions: </strong>Our findings demonstrates the prolonged CIT upregulates the expression of MYL9 in liver graft after LT. MYL9 activates HSCs and promotes fibrosis through a TLR4/MYD88/NF-κB signaling dependent manner.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101453"},"PeriodicalIF":7.1,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene. 托法替尼减轻PTPN2基因中IBD风险变异引起的SARS-CoV-2感染易感性增加
IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-03 DOI: 10.1016/j.jcmgh.2024.101447
Marianne R Spalinger, Golshid Sanati, Pritha Chatterjee, Rong Hai, Jiang Li, Alina N Santos, Tara M Nordgren, Michel L Tremblay, Lars Eckmann, Elaine Hanson, Michael Scharl, Xiwei Wu, Brigid S Boland, Declan F McCole

Background & aims: Coronavirus disease (COVID-19), caused by severe acquired respiratory syndrome-Coronavirus-2 (SARS-CoV-2), triggered a global pandemic with severe medical and socioeconomic consequences. Although fatality rates are higher among the elderly and those with underlying comorbidities, host factors that promote susceptibility to SARS-CoV-2 infection and severe disease are poorly understood. Although individuals with certain autoimmune/inflammatory disorders show increased susceptibility to viral infections, there is incomplete knowledge of SARS-CoV-2 susceptibility in these diseases. The aim of our study was to investigate whether the autoimmunity risk gene, PTPN2, which also confers elevated risk to develop inflammatory bowel disease, affects susceptibility to SARS-CoV-2 viral uptake.

Methods: Using samples from PTPN2 genotyped patients with inflammatory bowel disease, PTPN2-deficient mice, and human intestinal and lung epithelial cell lines, we investigated how PTPN2 affects expression of the SARS-CoV-2 receptor angiotensin converting enzyme 2 (ACE2), and uptake of virus-like particles expressing the SARS-CoV2 spike protein and live SARS-CoV-2 virus.

Results: We report that the autoimmune PTPN2 loss-of-function risk variant rs1893217 promotes expression of the SARS-CoV-2 receptor, ACE2, and increases cellular entry of SARS-CoV-2 spike protein and live virus. Elevated ACE2 expression and viral entry were mediated by increased Janus kinase-signal transducers and activators of transcription signaling and were reversed by the Janus kinase inhibitor, tofacitinib.

Conclusion: Collectively, our findings uncover a novel risk biomarker for increased expression of the SARS-CoV-2 receptor and viral entry and identify a clinically approved therapeutic agent to mitigate this risk.

背景:由SARS-CoV-2引起的冠状病毒病(COVID-19)引发了全球大流行,造成了严重的医疗和社会经济后果。虽然老年人和有潜在合并症的人的死亡率较高,但人们对促进对SARS-CoV-2感染和严重疾病易感性的宿主因素知之甚少。尽管患有某些自身免疫性/炎症性疾病的个体对病毒感染的易感性增加,但对这些疾病中SARS-CoV-2易感性的了解尚不完整。本研究的目的是调查自身免疫风险基因PTPN2是否影响对SARS-CoV-2病毒摄取的易感性,PTPN2也会增加患炎症性肠病(IBD)的风险。方法:利用PTPN2基因型IBD患者、PTPN2缺陷小鼠和人肠道和肺上皮细胞系的样本,研究PTPN2如何影响SARS-CoV-2受体ACE2的表达,以及表达SARS-CoV2刺突蛋白和活SARS-CoV-2病毒样颗粒的摄取。结果:我们报道了自身免疫性PTPN2功能丧失风险变异rs1893217促进SARS-CoV-2受体ACE2的表达,并增加SARS-CoV-2刺突蛋白和活病毒的细胞进入。ACE2表达升高和病毒进入是由JAK- stat信号传导增加介导的,并被JAK抑制剂托法替尼逆转。总之,我们的研究结果揭示了SARS-CoV-2受体表达增加和病毒进入的一种新的风险生物标志物,并确定了一种临床批准的治疗剂来降低这一风险。
{"title":"Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene.","authors":"Marianne R Spalinger, Golshid Sanati, Pritha Chatterjee, Rong Hai, Jiang Li, Alina N Santos, Tara M Nordgren, Michel L Tremblay, Lars Eckmann, Elaine Hanson, Michael Scharl, Xiwei Wu, Brigid S Boland, Declan F McCole","doi":"10.1016/j.jcmgh.2024.101447","DOIUrl":"10.1016/j.jcmgh.2024.101447","url":null,"abstract":"<p><strong>Background & aims: </strong>Coronavirus disease (COVID-19), caused by severe acquired respiratory syndrome-Coronavirus-2 (SARS-CoV-2), triggered a global pandemic with severe medical and socioeconomic consequences. Although fatality rates are higher among the elderly and those with underlying comorbidities, host factors that promote susceptibility to SARS-CoV-2 infection and severe disease are poorly understood. Although individuals with certain autoimmune/inflammatory disorders show increased susceptibility to viral infections, there is incomplete knowledge of SARS-CoV-2 susceptibility in these diseases. The aim of our study was to investigate whether the autoimmunity risk gene, PTPN2, which also confers elevated risk to develop inflammatory bowel disease, affects susceptibility to SARS-CoV-2 viral uptake.</p><p><strong>Methods: </strong>Using samples from PTPN2 genotyped patients with inflammatory bowel disease, PTPN2-deficient mice, and human intestinal and lung epithelial cell lines, we investigated how PTPN2 affects expression of the SARS-CoV-2 receptor angiotensin converting enzyme 2 (ACE2), and uptake of virus-like particles expressing the SARS-CoV2 spike protein and live SARS-CoV-2 virus.</p><p><strong>Results: </strong>We report that the autoimmune PTPN2 loss-of-function risk variant rs1893217 promotes expression of the SARS-CoV-2 receptor, ACE2, and increases cellular entry of SARS-CoV-2 spike protein and live virus. Elevated ACE2 expression and viral entry were mediated by increased Janus kinase-signal transducers and activators of transcription signaling and were reversed by the Janus kinase inhibitor, tofacitinib.</p><p><strong>Conclusion: </strong>Collectively, our findings uncover a novel risk biomarker for increased expression of the SARS-CoV-2 receptor and viral entry and identify a clinically approved therapeutic agent to mitigate this risk.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101447"},"PeriodicalIF":7.1,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cellular and Molecular Gastroenterology and Hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1